Skip to content
Chemicals, Materials & Nutrition

Global CBD Ingredients Growth Opportunities

Regulatory Challenges and Product Development to Shape the Market’s Future Growth Potential

The cannabidiol (CBD) industry’s rapid growth reflects the many needs this compound meets. However, regulatory and health issues related to its use remain unaddressed. This research shines a light on the regulatory landscape and applications related to the global CBD industry.

The study’s geographic segmentation reflects the specific realities of North America; Europe, the Middle East, and Africa (EMEA); Asia-Pacific; and Latin America. Further segmentation breaks down CBD as an ingredient in end applications: Food and beverages, personal care and cosmetics, and single servings (capsules, oils, gummies). While several properties and benefits of using CBD are apparent, scientific evidence is lacking to demonstrate them effectively. Prescription CBD-based drugs must receive approval from competent authorities in each jurisdiction. The control and compliance of these medicines require clinical trials, while CBD does not. Therefore, the scope of this research does not consider pharmaceutically derived products.

The above deliverable is the latest addition to Frost & Sullivan’s Chemicals, Materials & Nutrition research and analyses, available through the Frost & Sullivan Growth Partnership Services, which help organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

Download Preview

Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled market intelligence, technology insights, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.